A US pharma company has developed an experimental drug that reduces lipoprotein(a) cholesterol by 94% with a single injection, offering new hope for heart attack prevention.
Simple ethical design
A US pharma company has developed an experimental drug that reduces lipoprotein(a) cholesterol by 94% with a single injection, offering new hope for heart attack prevention.
